Shows
Trials with Maya ZHow to Adopt a Beginner’s Mindset in Trials with Leen Kawas In this episode, Maya meets Dr. Leen Kawas. Dr. Kawas is creating a biotech-focused fund to support life science innovations, utilizing her background as an inventor, scientist, and entrepreneur. She first led and co-founded Athira, a company for late-stage clinical programs. She took it public in 2020, raising over $400 million. Notably, she was the first woman in 20 years in Washington State, and one of only 22 female founders in the US, to take a company public.Maya and Leen discuss the critical role of patient-centric clinical trial design and the importance of engaging with pa...2024-05-2243 min
Building BiotechsEmpowering Entrepreneurs with Leen Kawas, PhD, Managing General Partner at Propel Bio PartnersThis week, we had an insightful conversation with Leen Kawas, PhD, Managing General Partner at Propel Bio Partners. She shared her journey from studying pharmacy to founding a successful company (with a great exit) and now running a venture fund. She emphasizes the business case for the importance of DEI in the company leadership and in clinical trials. We also touched on tips on managing conflict in teams, fostering healthy communication, and the value of building a strong network and connections in the industry.Get Leen's favorite book: The Boys in the Boat: Nine Americans and Their Epic...2024-04-0338 min
Global Leaders Podcast by FCILife Sciences and Saudi Vision 2030: A Chat with Leen KawasIn conversation with Leen Kawas: the General Managing Partner of Propel Bio Partners, she spearheads investments in life sciences and healthcare technologies poised to revolutionize human health. With a background in clinical pharmaceutical research and successful entrepreneurship, Leen brings invaluable experience to the table. 2024-02-1925 min
Angel Invest BostonLeen Kawas - The Microbiome of BabiesAngel Scale Biotech: Learn More Leen Kawas PhD, managing general partner at Propel Bio Partners, invests in life science companies such as Persephone Biosciences and Inherent Bio that promise immediate benefits for humanity. An uplifting chat with a dynamic VC and founder. Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson. Highlights: Sal Daher Introduces Leen Kawas What Propel Bio Partners Does Persephone Biosciences "... It's a pipeline for probiotics. They're starting with infant probiotics..." "... is anybody else working in the space of...2023-02-2250 min
Talking Biotech with Dr. Kevin FoltaInspiring Innovations; State of Alzheirmer's Therapies - Dr. Leen KawasThis week's podcast has two parts. Dr. Leen Kawas , Managing General Partner at Propel Biopartners, speaks about how biotech startups can benefit from skilled oversight and capital provided from experts that understand the business/science ecosystem. In the second part we discuss the latest therapies for Alzheimer's Disease, and how trials and regulation can't follow traditional trajectories. Alzheimer's has variation in etiology, patients start treatments after a diagnosis which may be years after the disease is well established, and progression is dependent on many genetic factors. All of these variables make any assessments problematic. At the same time several n...2023-02-1145 min
Pretty Powerful Podcast with Angela GennariEpisode 38: Dr. Leen KawasDr. Leen Kawas has shattered ALL the glass ceilings in her quest to chase the American Dream. As a researcher, inventor and founder of a bioscience company, Leen fueled her passion for change with innovation and tenacity, while raising $400 million to lead her company into a groundbreaking IPO.
Dr. Kawas is the Managing General Partner of Propel Bio Partners. She is the co-founder of Athira and a co-inventor of its lead drug candidate ATH-1017, and also invented several of the innovative drug candidates in Athira’s pipeline. Dr. Kawas served as Athira’s chief executive officer and presid...2022-12-201h 06
Scale by Design - Venture Capital ShowS2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen KawasLeen Kawas, the Managing General Partner of Propel Bio Partners, shares how her unique background as a pharmacist, entrepreneur, scientist, and investor has influenced her perspective on startups and the drug development lifecycle. Our host James Mackey, SecureVision CEOListen to our full episode list here:https://www.scalebydesign.io/Follow us:https://www.linkedin.com/company/scalebydesign/Our YouTube channel:https://www.youtube.com/@securevision1677#1 Rated Embedded Recruitment Firm on G2!https://www.g2.com/products/securevision/r...2022-12-2047 min
Alzheimer's SpeaksLearn About This Non-Invasive Clinical Trial for Alzheimer's DiseaseToday’s show is live and as always you are invited to call in and ask your questions or make comments at 323-870-4602.
Lori La Bey will be talking with Leen Kawas, the President and Chief Executive Officer of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Joining them will be Doctor Anton Porsteinsson, who is a Professor of Psychiatry, Neurology, Neuroscience, and Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, New York. He is also the Director of the University of R...2021-05-041h 00Alzheimer's SpeaksLearn About This Non-Invasive Clinical Trial for Alzheimer's DiseaseToday’s show is live and as always you are invited to call in and ask your questions or make comments at 323-870-4602. Lori La Bey will be talking with Leen Kawas, the President and Chief Executive Officer of Athira Pharma, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Joining them will be Doctor Anton Porsteinsson, who is a Professor of Psychiatry, Neurology, Neuroscience, and Medicine at the University of Rochester School of Medicine and Dentistry in Rochester, New York. He is also the Director of the University of R...2021-05-041h 00
Biotech 2050 Podcast49. Restoring connections for neurodegenerative diseases, Leen Kawas, CEO, Athira PharmaLeen Kawas, Ph.D., has served as our chief executive officer and as a member of our board of directors since January 2014. Previously, Dr. Kawas served as our vice president. Dr. Kawas serves on multiple boards, including the Washington Governor’s Life Science Advisory Board, Scientific Review Board for the Alzheimer’s Drug Discovery Foundation, and Alzheimer’s Association – Washington Chapter Board. She also served as the co-chair of the International Alzheimer's Association Business Consortium.
Dr. Kawas earned a Ph.D. in molecular pharmacology from Washington State University in 2011 and a pharmacy degree from the University of Jordan in 2008.2021-03-1018 min
Conversations in HealthcareA novel approach to treating neurodegenerative diseaseIn this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira’s recent IPO following a successful series B funding round, all during the pandemic. Hosted on Acast. See acast.com/privacy for more information.2020-12-0226 min
How to Live to 200 PodcastCat Poop and the Secrets of the MicrobiomeIvan Liachko – Co-founder & CEO at Phase Genomics Today’s guest is Ivan Liachko. Ivan is Co-Founder and CEO of a fascinating University of Washington spinout, Phase Genomics. With 20 years of experience and a Ph.D. in Genetics, Ivan is a leading expert in genetic/genomic research. Ivan and his teams at Phase Genomics have developed a new genomic discovery that, among other things, can help lead to longer lives and new drug developments. In this episode, we learn all about Lil Bub and how the internet famous cat’s poop helped Ivan discover entirely new organi...2019-01-2331 min
How to Live to 200 PodcastFinding a Cure for our Aging BrainsLeen Kawas – CEO, M3 Biotechnology "There's work that needs to be done and we're going to do it." - Leen Kawas Nothing better illustrates the grit, determination, and enthusiasm of today's guest, Leen Kawas. Leen is the CEO and president of M3 Biotechnology, a Seattle-based startup tackling diseases of the brain. As a leader in her field and an award-winning entrepreneur, she knows no bounds when it comes to tackling the daunting challenge of neurodegenerative diseases like Alzheimer's. As a Ph.D. student at Washington State University, Leen stumbled into an unlikely career as a star...2018-11-0744 min